Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Mol Model ; 26(10): 291, 2020 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-32995926

RESUMEN

Herein, we demonstrate effect of substituents on optoelectronic properties of discotic liquid crystals (DLCs) by using density functional theory (DFT) calculations at B3LYP/Lanl2Z level of theory. Three parent DLCs, namely, (1) benzene-1,3,5-triyl tris(3,5-dialkoxybenzoate), (2) N1, N3, N5-tris(3-alkoxyphenyl)benzene-1,3,5-tricarboxamide, and (3) trialkyl 4, 4', 4″-(benzenetricarbonyltris (azanediyl)) tribenzoate benzoate and their -N and -S group derivatives of 1, 2, and 3, were investigated to observe the change in optoelectronic response of these systems. The frontier molecular orbital studies and electron affinity values indicate that the studied compounds are stable against the oxygen and moisture present in air. The calculated charge transfer integrals, electron, and hole mobility values revealed that parent DLCs and their derivatives can be employed as an effective n-type material for OLEDs; however, derivatives have enhanced charge transfer values compared with their parents. For better understanding of the thermochemistry and effect of substituents, frequency calculations were carried out. P1-D4 derivative having R = -NH-CO-CH3 terminal group came out to be theoretically the most favored having the lowest ΔG value. Computed UV/visible spectroscopic analysis showed minimum absorbance and maximum transmittance for derivative P2-D1 having -S-NH2 substituent. Molecular electrostatic potential surfaces mapped at potential range, i.e., - 8.531e-3esu to + 8.531e-3esu, describe electrophilic and nucleophilic characteristics. Introduction of electron donor groups enhanced electrical conductivity, excitation energy, and charge transfer integral, thus increasing optoelectronic properties of DLCs. However, these claims require further experimental verification.

2.
PLoS One ; 13(10): e0205764, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30372448

RESUMEN

Pharmacodynamic interactions of three anthracycline antibiotics namely doxorubicin (DXH), epirubicin (EpiDXH) and daunorubicin (DNR) with DNA in the absence and presence of ascorbic acid (AA) as natural additive were monitored under physiological conditions (pH = 7.4, 4.7 and T = 309.5K). Route-1 (Anthracycline-AA-DNA) and Route-2 (Anthracycline-DNA-AA) were adopted to see the interactional behavior by cyclic voltammetry (CV) and UV-visible spectroscopy. In comparison to Route-2; voltammetric and spectral responses as well as binding constant (Kb) and Gibb's free energy change (ΔG) values revealed strongest and more favorable interaction of anthracycline-AA complex with DNA via Route-1. Kb, s (binding site sizes) and ΔG evaluated from experimental (CV, UV-Vis) and theoretical (molecular docking) findings showed enhanced binding strength of tertiary complexes as compared to binary drug-DNA complexes. The results were found comparatively better at pH 7.4. Consistency was observed in binding parameters evaluated from experimental and theoretical techniques. Diffusion coefficients (Do) and heterogeneous electron transfer rate constant (ks,h) confirmed the formation of complexes via slow diffusion kinetics. Percent cell inhibition (%Cinh) of anthracyclines for non-small cell cancer cell lines (NSCCLs) H-1299 and H-157 were evaluated higher in the presence of AA which further complimented experimental and theoretical results.


Asunto(s)
Antibióticos Antineoplásicos/farmacología , Antioxidantes/farmacología , Ácido Ascórbico/farmacología , ADN/metabolismo , Neoplasias/tratamiento farmacológico , Antibióticos Antineoplásicos/química , Antibióticos Antineoplásicos/uso terapéutico , Antioxidantes/química , Antioxidantes/uso terapéutico , Ácido Ascórbico/química , Ácido Ascórbico/uso terapéutico , Cardiotoxicidad/etiología , Cardiotoxicidad/prevención & control , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , ADN/química , Daunorrubicina/química , Daunorrubicina/farmacología , Daunorrubicina/uso terapéutico , Doxorrubicina/química , Doxorrubicina/farmacología , Doxorrubicina/uso terapéutico , Interacciones Farmacológicas , Epirrubicina/química , Epirrubicina/farmacología , Epirrubicina/uso terapéutico , Humanos , Concentración de Iones de Hidrógeno , Simulación del Acoplamiento Molecular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA